Lonza | LONN - Pre Tax Profit


Lonza reported CHF624M in Pre-Tax Profit for its fiscal semester ending in December of 2024.





Pre Tax Profit Change Date
Akzo Nobel EUR 148M 598M Mar/2026
Alcon AG USD 240M 24M Mar/2026
Almirall EUR 30.32M 22M Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
BASF EUR 1.07B 1.04B Dec/2025
Bayer EUR -3.37B 2.21B Dec/2025
Beiersdorf EUR 408.5M 43.5M Jun/2025
Covestro EUR -353M 344M Dec/2025
Demant DKK 1.64B 173M Dec/2025
Fresenius EUR 601M 122M Dec/2025
Fresenius Medical Care EUR 340M 168.46M Mar/2026
Geberit CHF 115.3M 73M Dec/2024
Genmab DKK 55M 427M Dec/2025
Givaudan CHF 642M 292M Dec/2024
GlaxoSmithKline GBP 2.14B 919M Mar/2026
GN Store Nord DKK 450M 332M Dec/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Johnson Matthey GBP 110M 91M Dec/2025
Merck EUR 401M 886.1M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Philips EUR 466M 191M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sika AG CHF 738.8M 80.1M Jun/2025
Smith & Nephew USD 469M 70M Dec/2025
Solvay EUR 42M 58M Mar/2026
UCB EUR 789M 427M Jun/2025